Moody’s paints bright year-ahead outlook despite a year of downgrades and defaults.
Any Way You Slice It: Is Valeant a Safer Bet Following Debt Offering, Asset Sales?
Covenant Review digs into Valeant following recent asset sales and debt offerings.
Up, Down, All Around? Spending Gains, Savings Slip…and Treasury’s Rally
Latest government figures also show little inflation pressure, and perhaps some worrying signs ahead for consumption. Treasury yields have dipped on
Broadcom’s Very Risky Bet on Qualcomm
Broadcom’s bold offer may not be enough to net Qualcomm, but time may not be on Qualcomm’s side either.
A Rare Bright Spot for Mylan
Little has gone right for Mylan recently, so the company and its investors can be forgiven for embracing a new drug as its next engine for growth.
Saudi Crackdown Doesn’t Guarantee Aramco IPO — Or Higher Oil
Oil markets are rising after the Saudi heir apparent – a big proponent of state oil firm Aramco’s planned IPO – rounded up a swathe of potential